Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

Healthcare Biotechnology

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine... see more

Add To Watchlist

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > FDA, in Reversal, Limits Aduhelm’s Use to People W/ mild AD

View:

Post by Gbathat on Jul 15, 2021 7:42pm

FDA, in Reversal, Limits Aduhelm’s Use to People W/ mild AD

https://alzheimersnewstoday.com/2021/07/12/fda-limits-aduhelm-use-early-alzheimers-patients/

FDA, in Reversal, Limits Aduhelm’s Use to People W/ mild AD

120

Comment

Comment by M101 on Jul 15, 2021 8:56pm

hmm, I think we overcooked the pig. Lipstick?

Comment

Comment by DavidKingCanada on Jul 16, 2021 11:30am

Great news for PMN as now we can further develop PMN310 the Best in Class!

Comment

Comment by retiredcop on Jul 17, 2021 10:33am

PMN wants controversy and anger towards Biogen. When PMN can prove they have the superior product and can deal with concerns. The experts will be so relieved there is a better alternative to Biogen that they may go as far as holding a parade to celebrate. We want more controversy It helps our cause

Comment